TOLMAR Company Profile

✉ Email this page to a colleague

TOLMAR has eight approved drugs.

There are twelve US patents protecting TOLMAR drugs. There is one tentative approval on TOLMAR drugs.

There are thirty-seven patent family members on TOLMAR drugs in eighteen countries and two supplementary protection certificates in two countries.

International Patents:	37
US Patents:	12
Tradenames:	5
Ingredients:	4
NDAs:	8
Patent Litigation for TOLMAR:	See patent lawsuits for TOLMAR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tolmar	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No	11,564,933	⤷ Sign Up				⤷ Sign Up
Tolmar	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-003	Mar 27, 2019		RX	Yes	Yes	8,492,369	⤷ Sign Up	Y			⤷ Sign Up
Tolmar	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No	11,331,325	⤷ Sign Up				⤷ Sign Up
Tolmar	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-001	Mar 27, 2019		RX	Yes	No	11,331,325	⤷ Sign Up				⤷ Sign Up
Tolmar	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	SYRUP;ORAL	090054-001	Nov 15, 2010		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Tolmar	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-003	Mar 27, 2019		RX	Yes	Yes	8,778,916	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021379-001	Jul 24, 2002	6,395,293	⤷ Sign Up
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021731-001	Dec 14, 2004	8,470,359	⤷ Sign Up
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021379-001	Jul 24, 2002	9,283,282	⤷ Sign Up
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021343-001	Jan 23, 2002	6,773,714	⤷ Sign Up
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021343-001	Jan 23, 2002	6,395,293	⤷ Sign Up
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021379-001	Jul 24, 2002	5,599,552	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
European Patent Office	2985026	⤷ Sign Up
South Korea	20080009201	⤷ Sign Up
Spain	2930658	⤷ Sign Up
Brazil	PI0607549	⤷ Sign Up
Poland	2985026	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2006113505	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0162036	C300028	Netherlands	⤷ Sign Up	PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
0162036	2000C/032	Belgium	⤷ Sign Up	PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.